259 related articles for article (PubMed ID: 16781263)
21. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190
[TBL] [Abstract][Full Text] [Related]
22. Making unsafe abortion safe: medical method.
Pradhan P
Nepal Med Coll J; 2004 Dec; 6(2):147-51. PubMed ID: 16295750
[TBL] [Abstract][Full Text] [Related]
23. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
[TBL] [Abstract][Full Text] [Related]
24. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
Rossi B; Creinin MD; Meyn LA
Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336
[TBL] [Abstract][Full Text] [Related]
25. Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
Chen AY; Mottl-Santiago J; Vragovic O; Wasserman S; Borgatta L
Contraception; 2006 Apr; 73(4):415-9. PubMed ID: 16531178
[TBL] [Abstract][Full Text] [Related]
26. Mifepristone and misoprostol sequential regimen side effects, complications and safety.
Sitruk-Ware R
Contraception; 2006 Jul; 74(1):48-55. PubMed ID: 16781261
[TBL] [Abstract][Full Text] [Related]
27. Mifepristone medical abortion in Albania: results from a pilot clinical research study.
Bracken H; Gliozheni O; Kati K; Manoku N; Moisiu R; Shannon C; Tare V; Tasha I; Winikoff B;
Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):38-46. PubMed ID: 16546815
[TBL] [Abstract][Full Text] [Related]
28. The role of parity in medical abortion up to 49 days of amenorrhoea.
Lefebvre P; Cotte M; Monniez N; Norel G
Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):404-11. PubMed ID: 19117257
[TBL] [Abstract][Full Text] [Related]
29. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
[TBL] [Abstract][Full Text] [Related]
30. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
Heikinheimo O; Leminen R; Suhonen S
Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
[TBL] [Abstract][Full Text] [Related]
31. Abortion and emergency contraception: Chinese experience.
Xiao B
Chin Med J (Engl); 1997 Jan; 110(1):36-42. PubMed ID: 9594319
[TBL] [Abstract][Full Text] [Related]
32. [Study of histopathology of endometrium following termination of early pregnancy using mifepristone].
Qiu X; Li D; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):272-4. PubMed ID: 11326931
[TBL] [Abstract][Full Text] [Related]
33. Mifepristone vaginally in an early medical abortion regimen: a pilot study.
Sharma S; El-Refaey H; Mitchel H; Ozturk O; Rodeck C
Contraception; 2006 Mar; 73(3):261-4. PubMed ID: 16472567
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
Li L; Zhou Z; Huang L
Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
[TBL] [Abstract][Full Text] [Related]
35. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
[TBL] [Abstract][Full Text] [Related]
36. Study supports the introduction of early medical abortion in Turkey.
Akin A; Kocoglu GO; Akin L
Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
[TBL] [Abstract][Full Text] [Related]
37. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam.
Ngoc NT; Nhan VQ; Blum J; Mai TT; Durocher JM; Winikoff B
BJOG; 2004 Aug; 111(8):814-9. PubMed ID: 15270929
[TBL] [Abstract][Full Text] [Related]
38. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Rose SB; Shand C; Simmons A
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
[TBL] [Abstract][Full Text] [Related]
39. Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
Creinin MD; Hou MY; Dalton L; Steward R; Chen MJ
Obstet Gynecol; 2020 Jan; 135(1):158-165. PubMed ID: 31809439
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study of four cases with malignant gestation trophoblastic tumor after mifepristone abortion].
Jin L; Fan G; Yang X
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):733-5. PubMed ID: 11286033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
